Cytokinetics, Incorporated (NASDAQ:CYTK) Q4 2023 Earnings Call Transcript February 27, 2024 Cytokinetics, Incorporated misses on earnings expectations. Reported EPS is $-1.38 EPS, expectations were $-1.03. Cytokinetics, Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. And welcome ladies […]
Zealand Pharma, Eli Lilly show the potential of treating liver disease with weight loss drugs, while the Change Healthcare outage continues after a cyberattack.
Zealand Pharma, Eli Lilly show the potential of treating liver disease with weight loss drugs, while the Change Healthcare outage continues after a cyberattack.